Announcements Trials

Browse Landscape

Phase

Status

Recruiting 4 Active not recruiting 2 Not yet recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

ER+HER2- Breast Cancer 1

Interventions

Carboplatin 127 Cisplatin 125 Drug Therapy 117 Bevacizumab 102 Oxaliplatin 99 Capecitabine 99 Radiotherapy 97 Gemcitabine 87 tislelizumab 86 Paclitaxel 86 Cyclophosphamide 86 Specimen Handling 80 pembrolizumab 76 toripalimab 68 Magnetic Resonance Spectroscopy 65 Fluorouracil 63 Injections 62 sintilimab 58 Surgical Procedures, Operative 58 anlotinib 53 Docetaxel 52 130-nm albumin-bound paclitaxel 50 fludarabine 47 Standard of Care 46 Pemetrexed 45 Immune Checkpoint Inhibitors 45 Blood Specimen Collection 43 Biopsy 43 venetoclax 42 Leucovorin 42

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × 18-O-demethylcervinomycin A2 × Clear all

NCT07109284 2025-08-07

NeoSaciA

West China Hospital

Phase 2 Not yet recruiting

ER+HER2- Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡